Positive feedback loop
Semaglutide At a Glance Drug Class: GLP-1 receptor agonist Brand Names: Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral) Molecular Weight: 4,113 Daltons Half-Life: ~7 days (enables weekly dosing) FDA Approved: 2017 (Ozempic), 2019 (Rybelsus), 2021 (Wegovy) Compounding Status: Illegal since May 2025 (shortage resolved) The Semaglutide Timeline That Changed Everything Semaglutide's journey from diabetes drug to cultural phenomenon reads like a pharmaceutical thriller
GLP-1s GLP-1 receptor agonists help lower blood sugar levels and promote weight loss
Macular complications Although uncommon, some cases of macular edema have been reported while taking GLP-1 receptor agonists, such as semaglutide
It has been investigated in the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) program, which showed significant reductions in glycated hemoglobin (A1c) and body weight (BW) compared to placebo or other treatments [7,8,9,10,11,12,13,14]
It can also be found in fortified foods (foods that have certain vitamins and nutrients added to them) such as certain cereals, bread and nutritional yeast